Free shipping on all orders over $ 500

KYP-2047

Cat. No. M8258

All AbMole products are for research use only, cannot be used for human consumption.

KYP-2047 Structure
Synonym:

KYP2047

Size Price Availability Quantity
5mg USD 120 In stock
10mg USD 180 In stock
25mg USD 340 In stock
50mg USD 505 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

KYP-2047 is a potent and BBB-penetrating prolyl-oligopeptidase (POP) inhibitor, with an Ki value of 0.023 nM. KYP-2047 reduces glioblastoma proliferation through angiogenesis and apoptosis modulation. KYP-2047 clears the α-synuclein aggregates induced by oxidative stress in the neuronal cells. α-synuclein is the main component of Lewy bodies in Parkinson′s disease that cause neuronal cell death and dementia.

KYP-2047 (0-100 μM) decreases U-87, U-138 and A-172 cell viability in a concentration-dependent manner. KYP-2047 (0-100 μM) increases the pro-apoptotic protein Bax, p53 and caspase-3 expression whereas reduces Bcl-2 expression, and reduced significantly TGF-β expression.

KYP-2047 (0-5 mg/kg) significantly reduces tumor mass and neutrophil infiltration.

Chemical Information
Molecular Weight 339.43
Formula C20H25N3O2
CAS Number 796874-99-2
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Sarah Adriana Scuderi, et al. Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma

[2] Sarah Adriana Scuderi, et al. KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation

[3] Aaro J Jalkanen, et al. KYP-2047 penetrates mouse brain and effectively inhibits mouse prolyl oligopeptidase

[4] T T Myhnen, et al. A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

[5] Aaro J Jalkanen, et al. Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat

Related Apoptosis Products
23-Hydroxybetulinic acid

23-Hydroxybetulinic acid is a novel anticancer substance.

TH-302 (Evofosfamide)

TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM.

Se-Methylselenocysteine

Se-methylselenocysteine, a precursor of methyl selenium, has strong cancer chemoprophylaxis and antioxidant activity. Se-Methylselenocysteine has oral biological activity, can induce apoptosis.

Aloperine

Aloperine is exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.

Ezatiostat

Ezatiostat (TER199, TLK199) is a glutathione analog inhibitor of glutathione S-transferase (GST) P1-1. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation.

  Catalog
Abmole Inhibitor Catalog




Keywords: KYP-2047, KYP2047 supplier, Apoptosis, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.